LWAY Stock Recent News

Lifeway (LWAY) possesses solid growth attributes, which could help it handily outperform the market.

Lifeway Foods, Inc. (NASDAQ:LWAY ) Q2 2024 Earnings Conference Call August 13, 2024 9:00 AM ET Company Participants Julie Smolyansky - President and Chief Executive Officer Conference Call Participants Operator Good morning. Welcome to Lifeway Foods' Second Quarter 2024 Conference Call.

Lifeway Foods reported strong Q2'24 earnings, with sales up 25% YoY. The company remains undervalued despite positive earnings, with a price target of $24.09 and potential for future growth. Lifeway's focus on probiotic products like kefir, along with increasing brand loyalty, positions them well for continued success in the market.

Lifeway reported strong sales and earnings growth this morning. At the same time, the company's co-founder and former COO -- family of the current CEO -- are moving to replace the board and the CEO.

Lifeway Foods (LWAY) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.21 per share a year ago.

CHICAGO , Aug. 13, 2024 /PRNewswire/ -- Son and mother Edward and Ludmila Smolyansky, significant shareholders of Lifeway Foods, Inc. (NASDAQ: LWAY), today announced the filing of a consent statement with the U.S. Securities and Exchange Commission, marking the launch of their "Life Back to Lifeway" campaign. The campaign seeks to replace the health food company's current Board of Directors, including CEO Julie Smolyansky, with leadership committed to revitalizing the company with a strategic vision aligned with the best interests of its shareholders.

Demand for Bioavailable Foods like Kefir Soars Net sales of $49.2 million; up 25.3% year-over-year driven by volume growth of Lifeway Kefir 19th consecutive quarter of year-over-year growth MORTON GROVE, Ill. , Aug. 13, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (Nasdaq: LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today reported financial results for the second quarter ended June 30, 2024.

MORTON GROVE, Ill. , Aug. 6, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (Nasdaq: LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced it will report financial results for the second quarter ended June 30, 2024 on August 13, 2024 before market hours.

Lifeway dominates the kefir market, with over 90% market share. The global probiotics market, valued at $70.95 billion in 2023, is expected to reach $115-$128 billion by 2030, with a CAGR of 8.6%. When the global market for kefir expands, Lifeway is well-positioned to capitalize on international growth opportunities.

Specifically Calls for Resignation and Replacement of Lead Director Jason Scher, Directors Pol Sikar, Jody Levy, Dorri McWhorter, Perfecto Sanchez and CEO/Chairperson Julie Smolyansky Seeks New Independent Board to be Comprised of up to 8 members, including past Director and Co-Founder Ludmila Smolyansky, as well as an invitation to current and past Director Juan Carlos Dalto, whom the Smolyansky's feel is the only qualified independent Director Immediate Termination of Lifeway Foods Corporate Representative and Julie Smolyansky's "Chief of Staff" and Spouse, Jason Burdeen, a former jeweler, whom is believed to be acting as the defacto CEO and General Counsel of Lifeway Adoption of an Anti-Nepotism Policy to the Bylaws  Calls for Operational and Strategic Review of Business  Full Letter and Presentation Available www.lifebacktolifeway.com CHICAGO , July 18, 2024 /PRNewswire/ -- Ludmila and Edward Smolyansky ("The Smolyanskys"), who beneficially own approximately 29% of Lifeway Fo